CERo Therapeutics Holdings, Inc.
CERO · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,856 | -$5,417 | -$5,106 | -$1,048 |
| Dep. & Amort. | $273 | $268 | $269 | $285 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | -$515 | $891 | $461 | -$1,404 |
| Change in WC | $434 | -$364 | -$70 | $692 |
| Other Non-Cash | $1,460 | $0 | $0 | -$65 |
| Operating Cash Flow | -$3,205 | -$4,623 | -$4,446 | $4,146 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $500 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $500 | $0 | $0 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $20 |
| Stock Issued | -$1,391 | -$1,227 | $6,322 | $1,589 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,425 | $1,709 | $0 | -$122 |
| Financing Cash Flow | $1,425 | $2,722 | $6,322 | $1,487 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,281 | -$1,901 | $1,876 | -$53 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,303 | $5,204 | $3,327 | $2,562 |
| End Cash | $2,022 | $3,303 | $5,204 | $1,601 |
| Free Cash Flow | -$3,205 | -$4,623 | -$4,446 | $4,146 |